Cellogen Therapeutics Private Limited, a active private limited company, was established on 08 June 2021 in Dadri, Uttar Pradesh, India. Engaging in biotechnology within the hospital and medical care sector, it holds CIN: U85300UP2021PTC202881. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.60 M and a paid-up capital of ₹0.26 M.
Its leadership includes Tanveer Ahmad (Director), Gaurav Kharya (Director). Past directors included Faisal Nazir Mir, Kullampalayam Vasugamani Shanmugapriya, Tanveer Ahmad. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 06, 9Th Floor, Magnus Tower, Sector 73, Dadri, Uttar Pradesh, 201307.
U85300UP2021PTC202881
202881
08 June 2021
₹1.60 M
₹0.26 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Cellogen Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tanveer Ahmad | Director | 15 Dec 2023 | Current |
| Gaurav Kharya | Director | 08 Jun 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Dec 2023 | Past |
| Pramod Abcsdd | Director | 15 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cellogen Therapeutics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 52.84% increase in profit. The company's net worth Soared by an impressive increase of 1492.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Cellogen Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Cellogen Therapeutics has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cellogen Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellogen Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Cellogen Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Cellogen Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
Tanveer Ahmad was appointed as a Director was appointed as a Director on 15 Dec 2023 & has been associated with this company since 2 years 8 days . was recorded as a recent event.
Progress on Gaurav Kharya was appointed as a Director was appointed as a Director on 08 Jun 2021 & has been associated with this company since 4 years 6 months . was documented.
Cellogen Therapeutics Private Limited was registered on 08 Jun 2021 with Roc Kanpur & aged 4 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Cellogen Therapeutics Private Limited is U85300UP2021PTC202881.
Cellogen Therapeutics Private Limited is headquartered at Plot No. 06, 9Th Floor, Magnus Tower, Sector 73, Dadri, Uttar Pradesh, 201307.
Cellogen Therapeutics Private Limited was incorporated on 08 June 2021.
The current directors of Cellogen Therapeutics Private Limited are
The primary industry of Cellogen Therapeutics Private Limited is Hospital And Medical Care.
Cellogen Therapeutics Private Limited is unlisted.
The authorized capital of Cellogen Therapeutics Private Limited is ₹1.60 M, and the paid-up capital is ₹0.26 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX